©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Oncol. Dec 24, 2024; 15(12): 1501-1506
Published online Dec 24, 2024. doi: 10.5306/wjco.v15.i12.1501
Published online Dec 24, 2024. doi: 10.5306/wjco.v15.i12.1501
DEK::AFF2 fusion-associated middle ear non-keratinizing squamous cell carcinoma: A case report
Yi-Wen Sun, Ying Zhou, Xiao-Yang Liu, Dan-Hua Shen, Department of Pathology, Peking University People’s Hospital, Beijing 100044, China
Author contributions: Sun YW and Zhou Y designed the study; Zhou Y, Sun YW, and Liu XY performed the research; Zhou Y and Shen DH wrote the manuscript; all of the authors read and approved the final version of the manuscript to be published.
Informed consent statement: Written informed consent was obtained from the patient for publication of this case report.
Conflict-of-interest statement: All authors declare no conflict of interest in publishing the manuscript.
CARE Checklist (2016) statement: The authors have read the CARE Checklist (2016), and the manuscript was prepared and revised according to the CARE Checklist (2016).
Corresponding author: Dan-Hua Shen, MD, Chief Doctor, Department of Pathology, Peking University People’s Hospital, No. 11 Xizhimen South Street, Beijing 100044, China.
Received: June 30, 2024
Revised: September 19, 2024
Accepted: September 30, 2024
Published online: December 24, 2024
Processing time: 114 Days and 1.7 Hours
Revised: September 19, 2024
Accepted: September 30, 2024
Published online: December 24, 2024
Processing time: 114 Days and 1.7 Hours
Core Tip
Core Tip: DEK::AFF2 non-keratinizing squamous cell carcinoma remains an understudied entity because of its rarity. This rare variant warrants increased attention and further exploration due to its potential severity and metastatic ability.